[DOI] [PubMed] [Google Scholar] 123.Pencek R, Brunell SC, Li Y, Hoogwerf BJ, Malone J
This should be done under the guidance of a healthcare provider, who can balance the dose adjustment with the need to maintain effective diabetes or obesity management
In most cases, the discoloration fades within a few months after stopping the drug, and specific treatment is not required
For example, if you carry GLP1R variants associated with lower receptor sensitivity, your provider may recommend optimizing dietary fiber first or sequencing it carefully with compounded GLP-1 to maximize efficacy
Changes in Anthropometry and Cardiometabolic Parameters at Week 68 in Studies 2, 3 and 4 with WEGOVY Injection Missing data were imputed from retrieved subjects of the same randomized treatment arm (RD-MI)